Rights and permissions
About this article
Cite this article
Super responders show that hepatitis C therapy may be cut in half. Inpharma Wkly. 1567, 11–12 (2006). https://doi.org/10.2165/00128413-200615670-00032
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615670-00032